Our seven business services work cohesively to accelerate monetization for both investors and company clients.
From start-ups through commercial operations, we are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness.
From steering seed money to promising new life science ventures to facilitating private financing or raising public capital, Bloom Burton & Co. connects investors with attractive healthcare businesses poised for growth and profit.
The mergers and acquisitions advisory capability at Bloom Burton guides clients to conceptualize, structure and execute transactions to maximize returns and company performance.
Our equity analysts ask the right questions, dig deeper for answers and find details others miss. Our research division covers key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events.
Understanding the business opportunities to bring healthcare advances to market, and how to successfully exploit them, are key to any company’s commercial and financial success.
The Bloom Burton Investment Group exists to provide investors with curated investment vehicles that deliver a diversified portfolio of healthcare companies in a single investment.